AAAAAA
Results: 1-25/47
Authors:
CARTRON G
LINASSIER C
BREMOND JL
DESABLENS B
GEORGET MT
FIMBEL B
LUTHIER F
DUTEL JL
LAMAGNERE JP
COLOMBAT P
Citation: G. Cartron et al., CD5 NEGATIVE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL AND BIOLOGICAL FEATURES OF 42 CASES, Leukemia & lymphoma, 31(1-2), 1998, pp. 209-216
Authors:
BENBOUBKER L
LINASSIER C
DELAIN M
DEMURET A
CALAIS G
DEQUIN PF
LAMAGNERE JP
COLOMBAT P
Citation: L. Benboubker et al., MEDIASTINAL LARGE-CELL LYMPHOMA WITH SCLEROSIS REFRACTORY TO CONVENTIONAL CHEMOTHERAPY CAN RESPOND AFTER DAILY ORAL CYCLOPHOSPHAMIDE, Leukemia & lymphoma, 29(1-2), 1998, pp. 199-203
Authors:
COUTEAU C
MERADBOUDIA Z
LOTZ JP
LINASSIER C
BLAY JY
GLIGOROV J
ANDRE T
IZRAEL V
Citation: C. Couteau et al., TANDEM HIGH-DOSE CHEMOTHERAPY COMBINING VP-16 (1,800 MG M(2)) AND IFOSFAMIDE (IFM, 18,000 MG/M(2)) SUPPORTED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSIS SOFT-TISSUE SARCOMAS (STS) - A PILOT-STUDY/, Annals of oncology, 9, 1998, pp. 696-696
Authors:
HAZOUARD E
CLEMENT B
FERRANDIERE M
MAYELO V
LINASSIER C
LEGRAS A
Citation: E. Hazouard et al., MAJOR PERIPHERAL AND MEDULLARY EOSINOPHILIA REVEALING RENAL-CELL CANCER, La Presse medicale, 27(24), 1998, pp. 1218-1218
Authors:
RAVAUD A
AUDHUY B
GOMEZ F
ESCUDIER B
LESIMPLE T
CHEVREAU C
DOUILLARD JY
CATY A
GEOFFROIS L
FERRERO JM
LINASSIER C
DREVON M
NEGRIER S
Citation: A. Ravaud et al., SUBCUTANEOUS INTERLEUKIN-2, INTERFERON ALPHA-2A, AND CONTINUOUS-INFUSION OF FLUOROURACIL IN METASTIC RENAL-CELL CARCINOMA - A MULTICENTER PHASE-II TRIAL, Journal of clinical oncology, 16(8), 1998, pp. 2728-2732
Authors:
LINASSIER C
CAHN JY
DESABLENS B
SENSEBE L
VILQUE JP
WITZ F
COMBE M
LUTHIER F
DECONNINCK E
MALIVOIR B
COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Bone marrow transplantation, 21, 1998, pp. 269-269
Authors:
LOTZ JP
LINASSIER C
BLAY JY
Citation: Jp. Lotz et al., TANDEM HIGH-DOSE CHEMOTHERAPY (HDCT) COMBINING VP-16 (1.800 MG M-2) AND IFOSFAMIDE (IFM, 18.000 MG/M-2) SUPPORTED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR POOR-PROGNOSIS SOFT-TISSUE SARCOMAS (STS) - A PILOT-STUDY/, Bone marrow transplantation, 21, 1998, pp. 794-794
Authors:
MARTIN L
LANOTTE P
BENCHELLAL Z
LINASSIER C
BARIN F
VAILLANT L
Citation: L. Martin et al., SIMULTANEOUS ACUTE ACALCULOUS CHOLECYSTITIS AND VARICELLA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, La Revue de medecine interne, 19(8), 1998, pp. 578-578
Authors:
RODON P
GAUVAIN JB
LINASSIER C
BENBOUBKER L
LEVALLOIS D
MAIGRE M
GOUPILLE P
LUTHIER F
LUCAS V
DUGAY J
COLOMBAT P
Citation: P. Rodon et al., PROGNOSTIC FACTORS AND SURVIVAL IN ELDERLY PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 354-354
Authors:
ARSENE O
DELAIN M
LINASSIER C
BREMOND JL
COLOMBAT P
Citation: O. Arsene et al., A CASE OF VENOOCCLUSIVE DISEASE COMPLICATED BY SEVERE HEMORRHAGIC CYSTITIS SUCCESSFULLY TREATED WITH RECOMBINANT PLASMINOGEN-ACTIVATOR, HEM CELL TH, 39(4), 1997, pp. 205-207
Authors:
BENBOUBKER L
DOMENECH J
DELAIN M
PICHON E
BREMOND JL
LINASSIER C
COLOMBAT P
BINET C
Citation: L. Benboubker et al., LONG-TERM FOLLOW-UP OF MARROW PROGENITOR RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD GRAFTS, Experimental hematology, 25(8), 1997, pp. 289-289
Authors:
LINASSIER C
MACDOUGALL LK
DOMIN J
WATERFIELD MD
Citation: C. Linassier et al., MOLECULAR-CLONING AND BIOCHEMICAL-CHARACTERIZATION OF A DROSOPHILA PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOINOSITIDE 3-KINASE, Biochemical journal, 321, 1997, pp. 849-856
Authors:
RODON P
GAUVAIN JB
LINASSIER C
LUTHIER F
MAIGRE M
GOUPILLE P
CUSSON P
LUCAS V
DUGAY J
ALLAIS C
COLOMBAT P
Citation: P. Rodon et al., MULTIPLE-MYELOMA IN ELDERLY PATIENTS - A STUDY OF SURVIVAL, PROGNOSTIC FACTORS AND RESPONSE TO TREATMENT, Blood, 90(10), 1997, pp. 4108-4108
Authors:
BENBOUBKER L
DOMENECH J
DELAIN M
PICHON E
BREMOND JL
LINASSIER C
COLOMBAT P
BINET C
Citation: L. Benboubker et al., HEMATOPOIESIS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH MARROW OR BLOOD GRAFTS - COMPARISON OF LONG-TERM MARROW PROGENITOR RECOVERIES, Blood, 90(10), 1997, pp. 4152-4152
Authors:
LINASSIER C
CAHN JY
DESABLENS B
SENESEBE L
VILQUE JP
WITZ F
COMBE M
LUTHIER F
DECONNINCK E
MALIVOIR B
COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Blood, 90(10), 1997, pp. 1030-1030
Authors:
BENBOUBKER L
PICHON E
LINASSIER C
DELAIN M
VALAT C
FETISSOF F
TELLIER Z
LAMAGNERE JP
COLOMBAT P
Citation: L. Benboubker et al., THYMIDINE KINASE SERUM LEVEL IS A PREDICTIVE FACTOR FOR RESPONSE AND RELAPSE RATES AFTER FIRST LINE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS, Blood, 90(10), 1997, pp. 1499-1499
Authors:
FLEURY J
LEGROS M
COLOMBAT P
CURE H
TRAVADE P
TORTOCHAUX J
DIONET C
CHOLLET P
LINASSIER C
LAMAGNERE JP
BLAISE D
VIENS P
MARANINCHI D
PLAGNE R
Citation: J. Fleury et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE, Leukemia & lymphoma, 20(3-4), 1996, pp. 259-266
Authors:
LINASSIER C
FOUILLARD L
MILPIED N
TILLY H
PICO J
ABGRALL JF
COIFFIER B
HERBRECHT R
BIRON P
COLOMBAT P
Citation: C. Linassier et al., VALUE OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN 42 PATIENTSWITH FOLLICULAR LYMPHOMAS RESPONSIVE TO CONVENTIONAL CHEMOTHERAPY - AFRANCE AUTOGREFFE STUDY, Cancer detection and prevention, 20(1), 1996, pp. 11-19
Authors:
HERAULT O
DOMENECH J
ESTIENNE MH
LINASSIER C
COLOMBAT P
BINET C
Citation: O. Herault et al., SENSITIVITY OF HUMAN BONE-MARROW PROGENITORS TO STEM-CELL FACTOR BEFORE AND AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 145-145
Authors:
DAYAN A
DOMENECH J
ROINGEARD F
BREMOND JL
ESTIENNE MH
BENZOHRA A
LINASSIER C
Citation: A. Dayan et al., IN-VITRO ACTIVITY OF ALL-TRANS-RETINOIC ACID ALONE OR IN COMBINATION WITH G-CSF OR STEM-CELL FACTOR IN NORMAL HUMAN BONE-MARROW CELLS, Experimental hematology, 24(9), 1996, pp. 418-418
Authors:
COLOMBAT P
DELAIN M
DESBOIS I
DOMENECH J
BINET C
TABAH I
LAMAGNERE JP
LINASSIER C
Citation: P. Colombat et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ACCELERATES HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMA, Bone marrow transplantation, 18(2), 1996, pp. 293-299
Authors:
FENAUX P
BINET JL
LEPORRIER M
TRAVADE P
PIGUET H
LINASSIER C
DESABLENS B
DREYFUS B
BRIZARD CP
MURGUE B
RUSSET T
SOUTEYRAND P
JOHNSON S
PHILLIPS MJ
HIDDEMANN W
SMITH A
ROATH S
LOFFLER H
BJORKHOLM M
OSBY E
EMMERICH B
COIFFIER B
THIEL E
KNAUF W
JULIUSSON G
MARCUS R
PRENTICE AG
COPPLESTONE JA
FREUND M
MILLIGAN PW
WINFIELD D
YIN J
HELLRIEGEL KP
HOSSFELD DK
KIMBY E
BURNETT AK
LISTER TA
LUCIE N
KANZ L
LERNER R
LINDEMALM C
CHILD A
HAMBLIN T
OSCIER D
SMITH JG
SINGER RJ
PARKER A
WHITTAKER J
WYLD P
SMITH AG
Citation: P. Fenaux et al., MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Lancet, 347(9013), 1996, pp. 1432-1438
Authors:
ARSENE O
LINASSIER C
QUENTIN R
LEGRAS A
COLOMBAT P
Citation: O. Arsene et al., DEVELOPMENT OF LISTERIOSIS DURING VANCOMYCIN THERAPY IN A NEUTROPENICPATIENT, Scandinavian journal of infectious diseases, 28(4), 1996, pp. 415-416
Authors:
KRAVTZOFF R
COLOMBAT P
DESBOIS I
LINASSIER C
MUH JP
PHILIP T
BLAY JY
GARDENBAS M
POUMIERGASCHARD P
LAMAGNERE JP
CHASSAIGNE M
ROPARS C
Citation: R. Kravtzoff et al., TOLERANCE EVALUATION OF L-ASPARAGINASE LOADED IN RED-BLOOD-CELLS, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 221-225
Authors:
PIGNON B
WITZ F
DESABLENS B
LEPRISE PY
FRANCOIS S
LINASSIER C
BERTHOU C
CAILLOT D
LIOURE B
CAHN JY
CASASSUS P
SADOUN A
AUDHUY B
GUYOTAT D
BRIERE J
VILQUE JP
BARANGER L
POLIN V
BERTHAUD P
HURTELOUP P
HERVE P
HAROUSSEAU JL
Citation: B. Pignon et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE, British Journal of Haematology, 94(2), 1996, pp. 333-341